<DOC>
	<DOCNO>NCT01958320</DOCNO>
	<brief_summary>The primary goal trial compare two different Patent Ductus Arteriosus ( PDA ) treatment approach : 1 ) `` early treatment '' approach 2 ) `` conservative '' approach . For purpose study infant enrol delivered 28 week gestation moderate/large PDA present 5-7 day birth . The hypothesis : treatment moderate size patent ductus arteriosus ( PDA ) decrease time need assisted respiratory support , diuretic therapy , gavage feeding assistance , addition decrease incidence ductus ligation need future outpatient cardiology follow-up appointment . The investigator hypothesize one benefit occur without increase time take achieve full enteral feeding incidence necrotizing enterocolitis ( NEC ) spontaneous intestinal perforation ( SIP ) .The investigator compare effectiveness early pharmacologic treatment control group conservatively manage infant receive treatment meet specific criterion `` rescue treatment '' .</brief_summary>
	<brief_title>Early Treatment Versus Delayed Conservative Treatment Patent Ductus Arteriosus</brief_title>
	<detailed_description>Prior study show , moderate/large Patent Ductus Arteriosus ( PDA ) still present 5 day birth ( among infant deliver 23 0/7 25 6/7 week gestation ) 7 day birth ( among infant deliver 26 0/7 27 6/7 week gestation ) , persist least another 4-12 week leave untreated .</detailed_description>
	<mesh_term>Enterocolitis , Necrotizing</mesh_term>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Enterocolitis</mesh_term>
	<mesh_term>Intestinal Perforation</mesh_term>
	<criteria>This prospective randomized , multicenter , control trial enroll infant deliver 23 &amp; 0/7 27 &amp; 6/7 week gestation : 1. infant must 514 day old ( deliver 23 0/7 25 6/7 week ) 714 day old ( deliver 26 &amp; 0/7 27 &amp; 6/7 week ) 2. `` moderate size PDA '' ( define PDA echocardiogram least one follow criterion : internal ductus diameter ≥1.5 mm/kg ( PDA : LPA ratio ≥0.5 ) , ductus flow velocity ≤2.5 m/s mean pressure gradient across ductus &lt; 8 mm , LA/Ao ratio ≥1.5 , leave pulmonary artery diastolic ( mean ) flow velocity &gt; 0.2 ( &gt; 0.42 ) m/sec , respectively , and/or reverse diastolic flow descend aorta ) ( 13 , 68 , 69 ) 3. receive respiratory support consist either mechanical ventilation , nasal CPAP , SiPAP , nasal cannula flow ≥2 L/min . prior treatment indomethacin , ibuprofen , acetaminophen , contraindication use indomethacin , ibuprofen , acetaminophen ( include : hydrocortisone administration within 24 hr , urine output &lt; 1 ml/kg/h precede 8 h , serum creatinine level &gt; 1.6 mg/dl , platelet count &lt; 50 , 000/mm3 , abnormal coagulation study , total bilirubin concentration ( mg/dL ) &gt; 8 x weight ( kg ) ) , chromosomal anomaly , congenital acquire gastrointestinal anomaly , prior episode necrotizing enterocolitis intestinal perforation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Days</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>patent ductus arteriosus</keyword>
	<keyword>patent ductus arteriosus ligation</keyword>
	<keyword>necrotizing enterocolitis</keyword>
	<keyword>spontaneous intestinal perforation</keyword>
</DOC>